Skip to main content

Advertisement

Log in

A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside

  • Original Research
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

The number of genetically defined Primary Immunodeficiency Diseases (PID) has increased exponentially, especially in the past decade. The biennial classification published by the IUIS PID expert committee is therefore quickly expanding, providing valuable information regarding the disease-causing genotypes, the immunological anomalies, and the associated clinical features of PIDs. These are grouped in eight, somewhat overlapping, categories of immune dysfunction. However, based on this immunological classification, the diagnosis of a specific PID from the clinician’s observation of an individual clinical and/or immunological phenotype remains difficult, especially for non-PID specialists. The purpose of this work is to suggest a phenotypic classification that forms the basis for diagnostic trees, leading the physician to particular groups of PIDs, starting from clinical features and combining routine immunological investigations along the way. We present 8 colored diagnostic figures that correspond to the 8 PID groups in the IUIS Classification, including all the PIDs cited in the 2011 update of the IUIS classification and most of those reported since.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

αFP:

Alpha- fetoprotein

Ab:

Antibody

AD:

Autosomal dominant inheritance

ADA:

Adenosine deaminase

Adp:

Adenopathy

AIHA:

Auto-immune hemolytic anemia

AML:

Acute myeloid leukemia

Anti PSS:

Anti- pneumococcus polysaccharide antibodies

AR:

Autosomal recessive inheritance

BL:

B lymphocyte

CAPS:

Cryopyrin-associated periodic syndromes

CBC:

Complete blood count

CD:

Cluster of differentiation

CGD:

Chronic granulomatous disease

CID:

Combined immunodeficiency

CINCA:

Chronic infantile neurologic cutaneous and articular syndrome

FCM*:

Flow cytometry available

CMML:

Chronic myelo-monocytic leukemia

CNS:

Central nervous system

CVID:

Common variable immunodeficiency disorders

CT:

Computed tomography

CTL:

Cytotoxic T-lymphocyte

DA:

Duration of attacks

Def:

Deficiency

DHR:

DiHydroRhodamine

Dip:

Diphtheria

EBV:

Epstein-barr virus

EDA:

Anhidrotic ectodermal dysplasia

EDA-ID:

Anhidrotic ectodermal dysplasia with immunodeficiency

EO:

Eosinophils

FA:

Frequency of attacks

FCAS:

Familial cold autoinflammatory syndrome

FISH:

Fluorescence in situ hybridization

GI:

Gastrointestinal

Hib:

Haemophilus influenzae serotype b

HIDS:

Hyper IgD syndrome

HIES:

Hyper IgE syndrome

HIGM:

Hyper Ig M syndrome

HLA:

Human leukocyte antigen

HSM:

Hepatosplenomegaly

Hx:

Medical history

Ig:

Immunoglobulin

IL:

Interleukin

LAD:

Leukocyte adhesion deficiency

MKD:

Mevalonate kinase deficiency

MSMD:

Mendelian susceptibility to mycobacteria disease

MWS:

Muckle-Wells syndrome

N:

Normal, not low

NK:

Natural killer

NKT:

Natural killer T cell

NN:

Neonate

NOMID:

Neonatal onset multisystem inflammatory disease

NP:

Neutropenia

PAPA:

Pyogenic sterile arthritis pyoderma gangrenosum, Acne syndrome

PMN:

Neutrophils

PT:

Platelet

SCID:

Severe combined immune deficiencies

Sd:

Syndrome

SLE:

Systemic lupus erythematosus

SPM:

Splenomegaly

Subcl:

IgG subclass

TCR:

T-cell receptor

Tet:

Tetanus

TL:

T lymphocyte

TNF:

Tumor necrosis factor

TRAPS:

TNF receptor-associated periodic syndrome

WBC:

White blood cells

XL:

X-linked

References

  1. Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:54.

    Article  PubMed  Google Scholar 

  2. Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131(2):314–23.

    Article  PubMed  Google Scholar 

  3. Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular & cellular approach. 2nd ed. New York: Oxford University Press; 2007.

    Google Scholar 

  4. Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.

    Article  PubMed  CAS  Google Scholar 

  5. Notarangelo LD, Casanova JL. Primary immunodeficiencies: increasing market share. Curr Opin Immunol. 2009;21:461–5.

    Article  PubMed  CAS  Google Scholar 

  6. Conley ME, Notarangelo LD, Casanova JL. Definition of primary immunodeficiency in 2011: a “trialogue” among friends. N Y Acad Sci. 2011;1238:1–6.

    Article  Google Scholar 

  7. Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2012. doi:10.1007/s10875-012-9751-7.

    PubMed  Google Scholar 

  8. de Vries E, European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108–19.

    Article  PubMed  Google Scholar 

  9. Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S297–305.

    Article  PubMed  Google Scholar 

  10. Admou B, Haouach K, Ailal F, Benhsaien I, Barbouch MR, Bejaoui M, et al. Primary immunodeficiencies: diagnosis approach in emergent countries (African Society for Primary Immunodeficiencies). Immunol Biol Spec. 2010;25(5–6):257–65.

    Google Scholar 

  11. Samarghitean C, Ortutay C, Vihinen M. Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters. J Immunol. 2009;183(11):7569–75.

    Article  PubMed  CAS  Google Scholar 

  12. Perreault S, Bernard G, Lortie A, Le Deist F, Decaluwe H. Ataxia-telangiectasia presenting with a novel immunodeficiency. Pediatr Neurol. 2012;46(5):322–4.

    Article  PubMed  Google Scholar 

  13. Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080–7.

    Article  PubMed  CAS  Google Scholar 

  14. Pessach I, Walter J, Notarangelo LD. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res. 2009;65(5 Pt 2):3R–12.

    Article  PubMed  Google Scholar 

  15. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97(1):81–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Dr Capucine Picard and Dr Claire Fieschi for their contribution to this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed Aziz Bousfiha.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bousfiha, A.A., Jeddane, L., Ailal, F. et al. A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside. J Clin Immunol 33, 1078–1087 (2013). https://doi.org/10.1007/s10875-013-9901-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-013-9901-6

Keywords

Navigation